Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

This study is using advanced molecular testing on blood, saliva, and tissue samples from people suspected of having lung cancer to see if genetic analysis can improve how early and accurately lung cancer is diagnosed. Researchers hope this approach can help personalize care before or alongside standard testing like bronchoscopy. **You may be eligible if...** - You are 18 or older - You are already scheduled for a bronchoscopy (a procedure to look inside your airways) as part of standard care - You have a moderate-to-high clinical risk of lung cancer based on your symptoms, scans, or history - You can provide a blood or saliva sample and archived tissue **You may NOT be eligible if...** - You are pregnant - You are currently incarcerated - You had comprehensive genetic testing (40+ gene panel) within the past year - You had comprehensive tumor genetic testing (250+ genes) within the past year Talk to your doctor to see if this trial is right for you.